Lessons from Heath Ledger’s tragic death: Don’t mix prescription drugs.
Merck hands over a cool $649 million to settle allegations about marketing transgressions. Also, launches authorized generic of Fosamax, which lost patent protection this month.
GSK continues slumping due to Avandia decline.
Some Q&A about that recent diabetes study that was halted due to deaths in the (intensive sugar reduction) treatment arm.
Botox and deaths. Careful out there!
A vaccine for high blood pressure? This looks pretty intriguing!
Eisai fails to get a shot at early approval for a new cancer drug.
Promising new Schering drug (vicriviroc) may help suppress HIV when used in combination with older drugs.
Leave a Reply